Int J Hyg Environ Health
Where are we at with lead? Current levels, time trend, and determinants of blood lead in New Zealand children and adults.
Mannetje A', Coakley J, Douwes J
A national biomonitoring survey was conducted in 2014-2016, to determine current blood lead levels (BLL) in New Zealand children and adults and identi ...
Read More
Source: PubMed
BMC Musculoskelet Disord
Prevalence of and factors associated with low Back pain, thoracic spine pain and neck pain in Bashkortostan, Russia: the Ural Eye and Medical Study.
Bikbov MM, Kazakbaeva GM, Zainullin RM, Salavatova VF, Gilmanshin TR, Arslangareeva II, Nikitin NA, Mukhamadieva SR, Yakupova DF, Panda-Jonas S, Khikmatullin RI, Aminev SK, Nuriev IF, Zaynetdinov AF, Uzianbaeva YV, Jonas JB
Back pain and neck pain are leading causes of the burden of disease worldwide, while information about their prevalence in Russia is missing. ...
Read More
Source: PubMed
Int J Behav Med 2020 Jan 31
Estradiol and Women's Health: Considering the Role of Estradiol as a Marker in Behavioral Medicine.
Rieder JK, Darabos K, Weierich MR
The sex hormone estradiol, as measured through saliva, represents a non-invasive and cost-effective approach to understanding the influence of hormona ...
Read More
Source: PubMed
Maturitas
Psychological behavior patterns and coping with menopausal symptoms among users and non-users of hormone replacement therapy in Finnish cohorts of women aged 52-56 years.
Jalava-Broman J, Junttila N, Sillanmäki L, Mäkinen J, Rautava P
To identify subgroups of women who differ with respect to self-evaluated stress, hostility, optimism and sense of coherence, and to identify differenc ...
Read More
Source: PubMed
Gynecol Obstet Fertil Senol 2020 Jan 28
[Borderline ovarian tumours: CNGOFS Guidelines for clinical practice - Hormonal contraception and MHT/HRT after borderline ovarian tumour].
Rousset-Jablonski C, Pautier P, Chopin N, Lecuru F, Ray-Coquard I
Contraceptive options and menopause management are frequent clinical issues among women previously treated for a borderline ovarian tumour (BOT). ...
Read More
Source: PubMed
